The Link Between Obesity and Autoimmunity: Understanding the Impact of Metabolic Overload

The Link Between Obesity and Autoimmunity: Understanding the Impact of Metabolic Overload

Obesity has long been associated with various health issues, including cardiovascular disease, diabetes, and metabolic syndrome. However, emerging research suggests a link between obesity and autoimmunity, shedding light on how excessive weight can affect the body's immune system and increase the risk of developing autoimmune diseases.

The immunometabolic state of an individual plays a crucial role in maintaining immunological self-tolerance, which prevents the body from attacking its own tissues and organs. Metabolic overload from obesity can disrupt immunometabolism, leading to alterations in immune responses and an increased susceptibility to autoimmune diseases.

Adipose tissue, commonly known as fat, is not just a passive storage site for excess energy. It is an active organ that produces adipocytokines, molecules that influence systemic immune responses. Conversely, immune cells also impact adipocyte homeostasis and metabolism through the production of pro- and anti-inflammatory cytokines.

One key mechanism through which obesity affects the immune system is the activation of intracellular nutrient- and energy-sensing pathways, including the NACHT, LRR and PYD domains-containing protein 3 (NLRP3) inflammasome. This sensor of metabolic stress is triggered by an excess of glucose and lipids, particularly in macrophages. The chronic activation of innate and adaptive immune cells due to overnutrition leads to low-grade systemic inflammation, a hallmark of obesity.

The relationship between obesity and autoimmune conditions such as type 1 diabetes (T1D) and multiple sclerosis (MS) has been extensively studied. Studies have shown that obesity is a significant risk factor for these diseases. For example, young obese individuals have been found to have a 1.6- to 1.9-fold increase in the risk of developing MS during adolescence and young adulthood.

The mechanistic connection between obesity and autoimmunity lies in the hyperactivation of nutrient- and energy-sensing pathways, such as mechanistic target of rapamycin (mTOR). In obese patients with MS, the adipocytokine leptin, which is secreted in proportion to body mass index (BMI) to inhibit food intake, promotes inflammatory immune responses. Leptin overproduction in obesity impairs the proliferation of anti-inflammatory thymic regulatory T cells (Tregs) and enhances the conversion of conventional T cells into pathogenic inflammatory T helper 1 (TH1) and TH17 cells.

These findings highlight the role of nutrient- and leptin-induced mTOR overactivation in disrupting immune tolerance and promoting autoimmunity. In individuals with a normal BMI and physiological cycles of feeding and fasting, oscillations in mTOR activity in Tregs are associated with the maintenance of self-tolerance. However, these oscillations are lost in obesity due to excessive food intake.

Adipose tissue also secretes inflammatory cytokines and hormones such as interleukin-1 (IL-1), tumor necrosis factor-α (TNF-α), IL-6, IL-17, interferon-γ (IFN-γ), and leptin. These molecules contribute to a higher susceptibility to peripheral tissue damage and autoimmunity. The metabolic workload induced by nutrients, growth factors, and adipocytokines in an obesogenic Western diet may accelerate autoimmune disorders.

Understanding the link between obesity and autoimmunity opens up new possibilities for interventions. Behavioral changes and nutritional strategies such as diet, caloric restriction (CR), and fasting regimens have shown promising results in modulating immune responses and alleviating symptoms of autoimmune diseases. Studies have demonstrated that T cells reprogram their transcriptional signature toward anti-inflammatory properties during CR, limiting tissue damage and extending lifespan.

Furthermore, CR induces adaptations in the gut microbiota, leading to the production of anti-inflammatory metabolites that affect immunometabolism. Manipulating immunometabolism through immunometabolic interventions or drugs that mimic fasting, known as "pseudo-starvation," could be a valuable approach to down-regulate autoinflammatory responses.

In the context of multiple sclerosis, combining first-line drug treatments with metformin, a drug that regulates immunometabolism, has shown positive results in reducing disease activity and improving peripheral Treg numbers. Lowered circulating leptin and inflammatory cytokines, along with increased anti-inflammatory Tregs, were observed.

In conclusion, the link between obesity and autoimmunity highlights the intricate connections between metabolism, the immune system, and the development of autoimmune diseases. Adipose tissue and its secreted molecules play a crucial role in modulating systemic immune responses, while obesity-induced metabolic overload disrupts immunometabolism and impairs self-tolerance.

Taking action to mitigate the risk of autoimmune diseases in the context of obesity involves lifestyle changes and nutritional strategies. Here are three actionable pieces of advice:

1. Maintain a healthy weight: Strive to achieve and maintain a healthy BMI through regular exercise and a well-balanced diet. This can help reduce the risk of developing autoimmune diseases associated with obesity.

2. Consider caloric restriction: Caloric restriction has shown promising results in modulating immune responses and promoting anti-inflammatory properties. Consult with a healthcare professional to discuss whether caloric restriction or fasting regimens are suitable for you.

3. Seek medical guidance: If you have a pre-existing autoimmune condition or are at a higher risk due to obesity, consult with a healthcare professional for personalized advice and guidance. They can help develop a comprehensive plan to manage your weight and minimize the risk of autoimmune diseases.

By understanding the complex interplay between obesity and autoimmunity, we can take proactive steps to promote a healthy immune system and reduce the burden of autoimmune diseases.